Mizuno, Ryuichi
Yasumizu, Yota
Tanaka, Nobuyuki
Takeda, Toshikazu
Morita, Shinya
Matsumoto, Kazuhiro
Kosaka, Takeo
Asanuma, Hiroshi
Oya, Mototsugu
Article History
Received: 24 May 2023
Accepted: 5 January 2024
First Online: 11 January 2024
Declarations
:
: Ethical approval of this study was approved by the Keio University School of Medicine Ethics Committee (ExternalRef removed). All procedures performed in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Because this was a retrospective cohort study, informed consent was obtained in the form of opt-out (Approval No 2013–0425, Ethics Committee of Keio University). Opt out was done on the web site of Keio University (ExternalRef removed).
: Informed consent for publication was obtained in the form of opt-out on the web-site (ExternalRef removed). Those who rejected were excluded.
: R. Mizuno MD has received honoraria from Bristol, Ono, Merck, Takeda, and Pfizer. M. Oya MD has received honoraria from Bayer, Bristol, Novartis, Ono, Merck, Takeda, MSD, and Pfizer. Other authors declare that they have no conflict of interest.